Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Retained Earnings (2020 - 2025)

Rapid Micro Biosystems' Retained Earnings history spans 6 years, with the latest figure at $12000.0 for Q3 2025.

  • For Q3 2025, Retained Earnings rose 100.0% year-over-year to $12000.0; the TTM value through Sep 2025 reached $12000.0, up 100.0%, while the annual FY2024 figure was $39000.0, 138.61% up from the prior year.
  • Retained Earnings for Q3 2025 was $12000.0 at Rapid Micro Biosystems, up from -$2000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $39000.0 in Q4 2024 and bottomed at -$486.5 million in Q1 2025.
  • The 5-year median for Retained Earnings is -$678500.0 (2023), against an average of -$102.7 million.
  • The largest annual shift saw Retained Earnings plummeted 31511300.0% in 2021 before it skyrocketed 138.61% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$315.1 million in 2021, then surged by 99.65% to -$1.1 million in 2022, then skyrocketed by 90.89% to -$101000.0 in 2023, then surged by 138.61% to $39000.0 in 2024, then crashed by 69.23% to $12000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Retained Earnings are $12000.0 (Q3 2025), -$2000.0 (Q2 2025), and -$486.5 million (Q1 2025).